HDAC1 and breast carcinoma: In addition, LSD1 suppresses breast cancer stem cell (CSC) properties by inhibiting epithelial–mesenchymal transition through its interaction with ubiquitously transcribed tetratricopeptide (UTX) and histone deacetylase 1 (HDAC1) [20].